During the past decade, Hematology and Oncology Consultants PC conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 44 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 41 clinical trials were completed. i.e. 683.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematology and Oncology Consultants PC" #1 sponsor was "National Cancer Institute (NCI)" with 49 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "Children's Oncology Group" with 8 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology and Oncology Consultants PC" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Hematology and Oncology Consultants PC" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Breast Carcinoma" (5 trials) and "Recurrent Fallopian Tube Carcinoma" (4 trials). Many other conditions were trialed in "Hematology and Oncology Consultants PC" in a lesser frequency.

Most popular intervention types in "Hematology and Oncology Consultants PC" are "Drug" (82 trials), "Other" (70 trials), "Biological" (46 trials), "Procedure" (24 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (22 trials), "Nivolumab" (15 trials), "Cisplatin" (13 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Hematology and Oncology Consultants PC" are 80 trials for "All" genders, 23 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hematology and Oncology Consultants PC". undefined are not yet recruiting, 15 are recruiting, 62 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Hematology and Oncology Consultants PC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology and Oncology Consultants PC, 3 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".